Procedural volume and outcomes of Impella support in cardiogenic shock - Report - MDSpire

Procedural volume and outcomes of Impella support in cardiogenic shock

  • By

  • Yuji Nishimoto

  • Atsushi Kikuchi

  • Yukihito Sato

  • Tetsuya Watanabe

  • Takahisa Yamada

  • Takaharu Hayashi

  • Masahiro Kumada

  • Yohei Sotomi

  • Yasushi Sakata

  • April 10, 2026

  • 0 min

Share

Clinical Report: Association Between Procedural Volume and Outcomes in Impella

Overview

This study analyzes the relationship between institutional procedural volume and in-hospital mortality in patients with cardiogenic shock receiving Impella support. Higher procedural volumes were associated with significantly lower mortality rates, suggesting a volume-outcome relationship similar to other cardiovascular interventions.

Background

The use of Impella devices for cardiogenic shock has increased, yet in-hospital mortality remains high. Understanding the impact of procedural volume on outcomes is crucial, as it may inform clinical practices and improve patient care. This study aims to clarify the volume-outcome relationship specifically for Impella use.

Data Highlights

Institutional Volume QuartileIn-Hospital Mortality30-Day Mortality
Q1 (0–7 cases)43.2%Not reported
Q2 (8–12 cases)46.9%Not reported
Q3 (13–18 cases)42.0%Not reported
Q4 (19–48 cases)40.4%Not reported

Key Findings

  • Overall in-hospital mortality was 43.5% across all quartiles.
  • Patients at Q4 institutions had significantly lower in-hospital mortality (adjusted OR 0.67) compared to Q1 institutions.
  • A nonlinear association was found between annual institutional volume and in-hospital mortality, with significant reductions at approximately 24 cases per year.
  • Higher rates of device-related complications were observed at Q4 institutions, but these did not correlate with increased mortality.
  • Patient-hospital distance did not affect mortality, emphasizing the importance of institutional volume over facility accessibility.

Clinical Implications

Clinicians should consider the volume of Impella procedures performed at their institutions when evaluating potential outcomes for patients with cardiogenic shock. Establishing structured multidisciplinary teams and focusing on increasing procedural volume may enhance patient care and reduce mortality rates.

Conclusion

The findings suggest that higher procedural volumes of Impella use are associated with improved patient outcomes in cardiogenic shock. This highlights the importance of institutional experience in managing complex cases effectively.

References

  1. Watanabe et al., Clinical Research in Cardiology, 2020 -- Evaluation of Mechanical Circulatory Support: A Propensity-Matched Study of Venoarterial Extracorporeal Membrane Oxygenation versus Impella in Patients Experiencing Cardiogenic Shock
  2. Clinical Research in Cardiology, 2023 -- Impact of Combined VAV-ECMO, Impella CP, and Impella RP on Hemodynamics
  3. Clinical Research in Cardiology, 2009 -- Enhanced Microcirculation in Acute ST-Elevation Myocardial Infarction Patients Receiving the Impella LP2.5 Percutaneous Left Ventricular Assist Device
  4. Clinical Research in Cardiology, 2024 -- Exploring Hemodynamic Optimization Techniques and Established Principles of Hemodynamics in Biventricular Mechanical Support for Cardiogenic Shock: Is Flow Balance a Key Factor?

Original Source(s)

Related Content